Thompson SW and Tonge D |
Bone cancer gain without the pain. |
2000 |
Nat. Med. |
pmid:10802700
|
Aubin JE and Bonnelye E |
Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption. |
2000 |
Medscape Womens Health |
pmid:10792853
|
Atkins GJ et al. |
Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. |
2000 |
J. Bone Miner. Res. |
pmid:10780856
|
Mukohyama H et al. |
The inhibitory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on osteoclast formation are associated with upregulation of osteoprotegerin and downregulation of RANKL and RANK. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:10777696
|
Bateman TA et al. |
Osteoprotegerin mitigates tail suspension-induced osteopenia. |
2000 |
Bone |
pmid:10773583
|
Ross FP |
RANKing the importance of measles virus in Paget's disease. |
2000 |
J. Clin. Invest. |
pmid:10712423
|
Capparelli C et al. |
Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy. |
2000 |
Cancer Res. |
pmid:10706080
|
Huang L et al. |
Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation. |
2000 |
Am. J. Pathol. |
pmid:10702390
|
Takayanagi H et al. |
Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. |
2000 |
Arthritis Rheum. |
pmid:10693864
|
Merewether LA et al. |
Development of disulfide peptide mapping and determination of disulfide structure of recombinant human osteoprotegerin chimera produced in Escherichia coli. |
2000 |
Arch. Biochem. Biophys. |
pmid:10683254
|
Makhluf HA et al. |
Age-related decline in osteoprotegerin expression by human bone marrow cells cultured in three-dimensional collagen sponges. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:10679262
|
Tricot G |
New insights into role of microenvironment in multiple myeloma. |
2000 |
Lancet |
pmid:10675068
|
Hofbauer LC et al. |
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. |
2000 |
J. Bone Miner. Res. |
pmid:10646108
|
Chikatsu N et al. |
Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:10631114
|
Itonaga I et al. |
Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages. |
2000 |
Ann. Rheum. Dis. |
pmid:10627423
|
Yamashita T et al. |
Retardation in bone resorption after bone marrow ablation in klotho mutant mice. |
2000 |
Endocrinology |
pmid:10614667
|
Kong YY et al. |
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. |
1999 |
Nature |
pmid:10580503
|
Nakagawa N et al. |
Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10548507
|
Nakagawa N et al. |
Basic fibroblast growth factor inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D(3) through suppressing the production of osteoclast differentiation factor. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10548488
|
Itonaga I et al. |
1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10529407
|
Thomas RJ et al. |
Breast cancer cells interact with osteoblasts to support osteoclast formation. |
1999 |
Endocrinology |
pmid:10499498
|
Hofbauer LC et al. |
Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. |
1999 |
Endocrinology |
pmid:10499489
|
Wickelgren I |
Mining the genome for drugs. |
1999 |
Science |
pmid:10475849
|
Hofbauer LC |
Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism. |
1999 |
Eur. J. Endocrinol. |
pmid:10474114
|
Lazner F et al. |
Osteopetrosis and osteoporosis: two sides of the same coin. |
1999 |
Hum. Mol. Genet. |
pmid:10469835
|
Sakata M et al. |
Expression of osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human dental mesenchymal cells and epithelial cells. |
1999 |
J. Bone Miner. Res. |
pmid:10469276
|
Morony S et al. |
A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3. |
1999 |
J. Bone Miner. Res. |
pmid:10469275
|
Hofbauer LC et al. |
Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. |
1999 |
Endocrinology |
pmid:10465311
|
Ito H et al. |
Hedgehog signaling molecules in bone marrow cells at the initial stage of fracture repair. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10462495
|
Lee SK and Lorenzo JA |
Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. |
1999 |
Endocrinology |
pmid:10433211
|
Roodman GD |
Cell biology of the osteoclast. |
1999 |
Exp. Hematol. |
pmid:10428500
|
Yasuda H et al. |
A novel molecular mechanism modulating osteoclast differentiation and function. |
1999 |
Bone |
pmid:10423033
|
Spelsberg TC et al. |
The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. |
1999 |
Mol. Endocrinol. |
pmid:10379881
|
Zhang XD et al. |
Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. |
1999 |
Cancer Res. |
pmid:10364001
|
Yano K et al. |
Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. |
1999 |
J. Bone Miner. Res. |
pmid:10234572
|
Kong YY et al. |
Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development. |
1999 |
Immunol. Cell Biol. |
pmid:10234557
|
Burgess TL et al. |
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. |
1999 |
J. Cell Biol. |
pmid:10225954
|
Nagai M and Sato N |
Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10208850
|
Hsu H et al. |
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10097072
|
Shalhoub V et al. |
Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. |
1999 |
J. Cell. Biochem. |
pmid:10022507
|
|
|
|
|
pmid:
|